June 20, 2021


Latest online bangla news | bd, world, Sports, photo, video live | Norobotsverification

Only Russia is ready to transfer ticker technology: Putin

President Vladimir Putin says Russia is the only country in the world that is ready to transfer technology and expand production abroad.

The Russian president made the remarks on Saturday. The remarks came during a virtual meeting with editors of several major international news agencies. This information was given in a report published online by Indian media NDTV.

The Russian-made corona vaccine ‘Sputnik-V’ has received initial permission to be produced locally by the Seram Institute of India. The permission was granted by the country’s drug regulator, the Drug Controller General of India (DCGI), on Friday at the request of Serum. As a result of this permission, ‘Sputnik-V’ vaccine can be produced in Seram’s factory in Pune. Putin made the remarks a day after the Sputnik-V was initially allowed to be produced locally by India’s Seram Institute.

Indian pharma company said. Reddy’s Laboratories approved the emergency use of the Russian vaccine last April. On the other hand, Panesia Biotech of India has started production of ‘Sputnik-V’ ticker in collaboration with Russian Direct Investment Fund (RDIF).

Putin said Russia is currently selling the Sputnik-V vaccine in six countries around the world. He described it as a big market for Russia.

Putin has denied any wrongdoing in the Sputnik-V vaccine. The Russian president said he was almost certain the allegations were being made for commercial reasons. But Russia is following the humanitarian side.

Putin said competition and commercial interests were at the root of the delay in registering Russian vaccines in Europe.

Putin also spoke of blaming China for spreading the coronavirus. He said there has been a lot of talk about this issue. This crisis should not be politicized.

In August last year, Russia approved the Sputnik-V vaccine. It is the first corona vaccine to receive state approval in the world. The vaccine was developed by the Russian vaccine manufacturer Gamalia Research Institute. It is funded by RDIF.